IC
QNCX icon

IEQ Capital’s Quince Therapeutics QNCX Stock Holding History

IEQ Capital’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.9K Sell
3,001
-1,895
-39% -$380K ﹤0.01% 1834
2025
Q4 		$3.28M Sell
4,896
-10
-0.2% -$5.03K 0.01% 642
2025
Q3 		$1.6M Buy
4,906
+2,710
+123% +$902K ﹤0.01% 840
2025
Q2 		$725K Sell
2,196
-1,838
-46% -$420K ﹤0.01% 976
2025
Q1 		$1.07M Buy
+4,034
New +$1.23M 0.01% 735
2024
Q2 		– Sell
-113
Closed -$23.9K – 1033
2024
Q1 		$23.9K Buy
+113
New +$28.1K ﹤0.01% 962

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

IEQ Capital's QNCX Position: Q1 2026 in Review

IEQ Capital reduced its Quince Therapeutics (QNCX) stake by 39% in Q1 2026, selling an estimated $380K and leaving 3,001 shares worth $60.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

IEQ Capital first reported a position in QNCX in Q1 2024 and has held it in 6 quarters since. The position peaked at $3.28M in Q4 2025. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • IEQ Capital held 3,001 shares of Quince Therapeutics worth $60.9K as of Q1 2026.
  • IEQ Capital sold 1,895 Quince Therapeutics shares in Q1 2026, an estimated $380K.
  • Quince Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1834 holding.
  • IEQ Capital first reported a position in Quince Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • IEQ Capital's Quince Therapeutics position peaked at $3.28M in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.